FilingFirehose · free AI preview
INOVIO PHARMACEUTICALS, INC.
INO · AI-generated SEC analysis preview · refreshes when data changes
Over the last 90 days, Inovio Pharmaceuticals (INO) has reported zero cyber incidents and zero red-flag 8-K filings—no bankruptcies, delistings, restatements, or officer departures detected in our ingestion pipeline. This low-signal window is a starting point only; a full year of filing history often reveals earlier warning signs that a quarterly snapshot may miss. The full $49 Report adds dilution risk scoring, detailed 8-K context and financing history, and AI-flagged risk signals across 12 months of SEC filings to build a complete risk picture.
Want the full 5-section $49 Report on INO?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.